RecruitingNCT06226051

Growing Little PEAPODS Study

Growing Little PEAPODS Study: Association Between Prematurity and Body Composition, Nutrition Practices, and Neurodevelopmental Outcomes

Sponsor

University of Wisconsin, Madison

Enrollment

120 participants

Start Date

Sep 4, 2024

Study Type

OBSERVATIONAL

Conditions

Premature Infant Premature Birth Intrauterine Growth Restriction Small for Gestational Age at Delivery Premature

Summary

The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development. Participants will: * have body growth measurements collected using the PEAPOD device * have nutritional information collected, and * be followed for neurodevelopmental outcomes Participants can expect to be in the study for 36 months.

Eligibility

Min Age: 22 WeeksMax Age: 32 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying PEAPOD Infant Body Composition measuring device for people with intrauterine growth restriction, premature, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.